Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

The Belgian Group KiOmed Pharma Opens the Market for Aesthetic Medicine

Summary by La Libre
The subsidiary of the pharmaceutical group KitoZyme, led by François Blondel, offers a second pillar of growth, after that dedicated to the treatment of knee osteoarthritis. The market is estimated at $1.5 billion and is expected to double by 2034. ...

1 Articles

La LibreLa Libre
Center

The Belgian Group KiOmed Pharma Opens the Market for Aesthetic Medicine

The subsidiary of the pharmaceutical group KitoZyme, led by François Blondel, offers a second pillar of growth, after that dedicated to the treatment of knee osteoarthritis. The market is estimated at $1.5 billion and is expected to double by 2034. ...

·Brussels, Belgium
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

La Libre broke the news in Brussels, Belgium on Wednesday, September 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Liège icon

Liège

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal